Pfizer is discontinuing a late-stage study of its cancer drug Sutent (SOO-tent) as an initial treatment for colon cancer because the drug is not proving effective enough.

Source: Yahoo! News Search Results for colon cancer
Pfizer discontinues Sutent colon cancer study (San Francisco Chronicle)

Excerpt from: Pfizer discontinues Sutent colon cancer study (San Francisco Chronicle)